Literature DB >> 24276527

Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme.

D Gareth R Evans1, Sarah Ingham, Sarah Dawe, L Roberts, F Lalloo, A R Brentnall, P Stavrinos, Anthony Howell.   

Abstract

Accurate individualized breast cancer risk assessment is essential to provide risk-benefit analysis prior to initiating interventions designed to lower breast cancer risk and start surveillance. We have previously shown that a manual adaptation of Claus tables was as accurate as the Tyrer-Cuzick model and more accurate at predicting breast cancer than the Gail, Claus model and Ford models. Here we reassess the manual model with longer follow up and higher numbers of cancers. Calibration of the manual model was assessed using data from 8,824 women attending the family history evaluation and screening programme in Manchester UK, with a mean follow up of 9.71 years. After exclusion of 40 prevalent cancers, 406 incident breast cancers occurred, and 385.1 were predicted (O/E = 1.05, 95 % CI 0.95-1.16) using the manual model. Predictions were close to that of observed cancers in all risk categories and in all age groups, including women in their forties (O/E = 0.99, 95 % CI 0.83-1.16). Manual risk prediction with use of adjusted Claus tables and curves with modest adjustment for hormonal and reproductive factors was a well-calibrated approach to breast cancer risk estimation in a UK family history clinic.

Entities:  

Mesh:

Year:  2014        PMID: 24276527     DOI: 10.1007/s10689-013-9694-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  21 in total

1.  Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.

Authors:  D Gareth R Evans; Fiona Lennard; Linda J Pointon; Susan J Ramus; Simon A Gayther; Nayanta Sodha; Gek E Kwan-Lim; Martin O Leach; Ruth Warren; Deborah Thompson; Douglas F Easton; Rosalind Eeles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

2.  Which risk model to use? Clinical implications of the ACS MRI screening guidelines.

Authors:  Elissa M Ozanne; Brian Drohan; Phil Bosinoff; Alan Semine; Michael Jellinek; Claire Cronin; Frederick Millham; Dana Dowd; Taryn Rourke; Caroline Block; Kevin S Hughes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-23       Impact factor: 4.254

Review 3.  Risk assessment and management of high risk familial breast cancer.

Authors:  D G R Evans; F Lalloo
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

Review 4.  Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Authors:  M H Gail; J P Costantino; J Bryant; R Croyle; L Freedman; K Helzlsouer; V Vogel
Journal:  J Natl Cancer Inst       Date:  1999-11-03       Impact factor: 13.506

Review 5.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1987

Review 6.  Familial breast cancer.

Authors:  D G Evans; I S Fentiman; K McPherson; D Asbury; B A Ponder; A Howell
Journal:  BMJ       Date:  1994-01-15

7.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

8.  Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

9.  A breast cancer prediction model incorporating familial and personal risk factors.

Authors:  Jonathan Tyrer; Stephen W Duffy; Jack Cuzick
Journal:  Stat Med       Date:  2004-04-15       Impact factor: 2.373

10.  The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

Authors:  A C Antoniou; A P Cunningham; J Peto; D G Evans; F Lalloo; S A Narod; H A Risch; J E Eyfjord; J L Hopper; M C Southey; H Olsson; O Johannsson; A Borg; B Pasini; B Passini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; L Tryggvadottir; K Syrjakoski; O-P Kallioniemi; H Eerola; H Nevanlinna; P D P Pharoah; D F Easton
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

View more
  9 in total

1.  Breast Cancer Risk Assessment at the Time of Screening Mammography: Perceptions and Clinical Management Outcomes for Women at High Risk.

Authors:  Nichole A Morman; Lindsey Byrne; Christy Collins; Kelly Reynolds; Jeffrey G Bell
Journal:  J Genet Couns       Date:  2017-01-26       Impact factor: 2.537

2.  Screening Strategy Modification Based on Personalized Breast Cancer Risk Stratification and its Implementation in the National Guidelines - Pilot Study.

Authors:  Mateja Krajc; D Gareth Evans; Ana Blatnik; Katarina Lokar; Tina Žagar; Sonja Tomšič; Janez Žgajnar; Vesna Zadnik
Journal:  Zdr Varst       Date:  2020-10-18

3.  The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation.

Authors:  Pål Møller; Astrid Stormorken; Marit Muri Holmen; Anne Irene Hagen; Anita Vabø; Lovise Mæhle
Journal:  Breast Cancer Res Treat       Date:  2014-03-12       Impact factor: 4.872

Review 4.  Risk determination and prevention of breast cancer.

Authors:  Anthony Howell; Annie S Anderson; Robert B Clarke; Stephen W Duffy; D Gareth Evans; Montserat Garcia-Closas; Andy J Gescher; Timothy J Key; John M Saxton; Michelle N Harvie
Journal:  Breast Cancer Res       Date:  2014-09-28       Impact factor: 6.466

5.  Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987-2020).

Authors:  Anthony Howell; Ashu Gandhi; Sacha Howell; Mary Wilson; Anthony Maxwell; Susan Astley; Michelle Harvie; Mary Pegington; Lester Barr; Andrew Baildam; Elaine Harkness; Penelope Hopwood; Julie Wisely; Andrea Wilding; Rosemary Greenhalgh; Jenny Affen; Andrew Maurice; Sally Cole; Julia Wiseman; Fiona Lalloo; David P French; D Gareth Evans
Journal:  Cancers (Basel)       Date:  2020-12-09       Impact factor: 6.639

6.  Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer.

Authors:  D Gareth Evans; Ashu Gandhi; Julie Wisely; Tara Clancy; Emma R Woodward; James Harvey; Lyndsey Highton; John Murphy; Lester Barr; Sacha J Howell; Fiona Lalloo; Elaine F Harkness; Anthony Howell
Journal:  Breast       Date:  2021-08-26       Impact factor: 4.380

7.  A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.

Authors:  Li Sun; Adam Brentnall; Shreeya Patel; Diana S M Buist; Erin J A Bowles; D Gareth R Evans; Diana Eccles; John Hopper; Shuai Li; Melissa Southey; Stephen Duffy; Jack Cuzick; Isabel Dos Santos Silva; Alec Miners; Zia Sadique; Li Yang; Rosa Legood; Ranjit Manchanda
Journal:  JAMA Oncol       Date:  2019-10-03       Impact factor: 31.777

8.  No strong evidence for increased risk of breast cancer 8-26 years after multiple mammograms in their 30s in females at moderate and high familial risk.

Authors:  D Gareth Evans; C John Kotre; Elaine Harkness; Mary Wilson; Anthony J Maxwell; Anthony Howell
Journal:  Br J Radiol       Date:  2016-01-21       Impact factor: 3.039

9.  Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women.

Authors:  D Gareth Evans; Sacha J Howell; Ashu Gandhi; Elke M van Veen; Emma R Woodward; James Harvey; Lester Barr; Andrew Wallace; Fiona Lalloo; Mary Wilson; Emma Hurley; Yit Lim; Anthony J Maxwell; Elaine F Harkness; Anthony Howell
Journal:  Breast Cancer Res Treat       Date:  2021-07-26       Impact factor: 4.872

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.